Welcome to the
Washington State Medical Oncology Society (WSMOS)
WSMOS membership represents majority of the medical cancer specialists treating cancer patients in Washington. Our mission is to support medical oncology clinicians in delivering the highest quality, value, and equitable care to all cancer patients in WA state.
check our
WSMOS News
March 9, 2021
Eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut […]
March 2, 2021
Eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut […]
check our
Corporate Member News
January 27, 2023
The National Comprehensive Cancer Network® (NCCN®) revised its guidelines—now Ribociclib (KISQALI®) is the only CDK4/6 inhibitor in combination with an AI designated as a Category 1 […]
October 1, 2021
G1 Therapeutics, Inc. secures permanent J Code for COSELA™ (trilaciclib). The code, J1448, is effective on October 1, 2021. Visit COSELA.com for more information.
check our
Corporate Member News
January 27, 2023
The National Comprehensive Cancer Network® (NCCN®) revised its guidelines—now Ribociclib (KISQALI®) is the only CDK4/6 inhibitor in combination with an AI designated as a Category 1 […]
October 1, 2021
G1 Therapeutics, Inc. secures permanent J Code for COSELA™ (trilaciclib). The code, J1448, is effective on October 1, 2021. Visit COSELA.com for more information.